Global Active Pharmaceutical Ingredient Market, By Type (Innovative, Generic), By Synthesis (Synthet

Published Date: | Report Code : HC1958644

X

Market Dynamics:

The Global Active Pharmaceutical Ingredient Market is expected to promise high growth owing to increasing demand due to the growing population base in geriatrics in recent years. This market has witnessed a number of key developments by major companies including Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Boehringer Ingelheim International GmbH., Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche Ltd., and Bayer AG… with a focus on organic as well as inorganic growth strategies. Developing regions including the Asia Pacific and the Middle East have been among the high potential markets with high growth in some of the key economies.

Segment Analysis:

Active Pharmaceutical Ingredients are chemically and biologically active drug elements that have a direct impact on disease cure, mitigation, therapy, and avoidance. Over the past few decades, the worldwide API industry has seen tremendous development due to enhanced use of drugs and biologics in disease therapy.

The growing acceptance of quality standards in the manufacturing of APIs such as Good Manufacturing Practices (GMP), present GMP (cGMP) and the worldwide implementation of rules for the International Conference on Harmonization (ICH) has helped to enhance safety standards. The API sector, on the other hand, faces difficulties such as shortening development time, lowering development costs, enhancing process design and meeting the quality standard without compromising profitability. A big amount of innovative drugs that have gone off-patent in latest years are likely to impact the worldwide API market. Technological innovations are in imminent need to preserve high volume profitability and low-value environment. Increasing oncology, cardiovascular, diabetes and lifestyle diseases, a growing number of clinics and diagnostic centers, growing the geriatric population in developing nations, increasing health care spending, increasing knowledge of disease and education are the main variables driving market growth.

Key Factors Impacting Market Growth:

  • Growing population base in geriatrics

  • Increasing preference in cancer treatment for targeted therapy

  • Increasing API outsourcing preferences

Regional Analysis:

North America, Western Europe, and the Asia Pacific by region are estimated to dominate the global active pharmaceutical ingredient during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for the global active pharmaceutical ingredient market during the forecast period. The US, Germany, France, UK, Canada, and Spain have been some of the major markets in the region. Asia Pacific is estimated to register one of the highest CAGR for the global active pharmaceutical ingredient market during the forecast period. This region has witnessed strategic investments by global companies to cater to the growing demand in recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for the global active pharmaceutical ingredient market in the region. Other regions including the Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for global active pharmaceutical ingredients during the forecast period.

Companies Covered: Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Boehringer Ingelheim International GmbH., Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche Ltd., and Bayer AG…

Market Segmentation:

By Type:

  • Innovative

  • Generic

By Synthesis:

  • Synthetic Active Pharmaceutical Ingredients

    • Innovative Synthetic APIs

    • Generic Synthetic APIs

  • Biotech Active Pharmaceutical Ingredients

    • Monoclonal Antibodies

    • Hormones & Growth Factors

    • Cytokines

    • Fusion Proteins

    • Recombinant Vaccines

    • Therapeutic Enzymes

    • Blood Factors

  • Biotech Active Pharmaceutical Ingredients

    • Mammalian Expression Systems

    • Microbial Expression Systems

    • Yeast Expression Systems

    • Insect Expression Systems

    • Other Expression Systems

By Drug Type:

  • Innovative Drugs

  • Generic Prescription

  • Over-the-counter (OTC) Drugs

By Therapy Area:

  • Oncology Drugs

  • Non-steroidal Anti-inflammatory Drugs

  • Cardiovascular Drugs

  • Anti-diabetic Drugs

  • Neurology Drugs

  • Musculoskeletal drugs

  • Others

By Region:

  • North America

    • By Country (US, Canada, Mexico)

    • By Type

    • By Synthesis

    • By Drug Type

    • By Therapy Area

  • Western Europe:

    • By Country (Germany, UK, France, Spain, Rest of Western Europe)

    • By Type

    • By Synthesis

    • By Drug Type

    • By Therapy Area

  • Eastern Europe:

    • By Country (Russia, Turkey, Rest of Eastern Europe)

    • By Type

    • By Synthesis

    • By Drug Type

    • By Therapy Area

  • Asia Pacific

    • By Country (China, Japan, India, Rest of Asia Pacific)

    • By Type

    • By Synthesis

    • By Drug Type

    • By Therapy Area

  • Middle East:

    • By Country (UAE, Qatar, Iran, Saudi Arabia, Rest of Middle East)

    • By Type

    • By Synthesis

    • By Drug Type

    • By Therapy Area

  • Rest of the World

    • By Region (Latin America, Brazil, Rest of the World)

    • By Type

    • By Synthesis

    • By Drug Type

    • By Therapy Area

Reasons To Buy This Report:

  • Market size estimation of the active pharmaceutical ingredient market on a regional and global basis

  • The unique research design for market size estimation and forecast

  • Profiling of major companies operating in the market with key developments

  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment

  • By Sub-segment

  • By Region/Country

For more information, contact:[email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

 Regional Analysis

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy